X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse GSK Consumer with THE COCA COLA COMPANY - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs COCA COLA (US) - Comparison Results

GSK CONSUMER    Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

COCA COLA (US)
   Change

The Coca Cola Company is the world’s largest beverage company. It owns and markets more than 500 non-alcoholic beverage brands including soft drinks, fruit juices, sport drinks and other beverages. It has four of the world’s top five sparkling bevera... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK CONSUMER   COCA COLA
EQUITY SHARE DATA
    GSK CONSUMER
Mar-18
COCA COLA
Dec-14
GSK CONSUMER/
COCA COLA
5-Yr Chart
Click to enlarge
High Rs6,7933,209-   
Low Rs4,9192,631-   
Sales per share (Unadj.) Rs1,026.3751.2-  
Earnings per share (Unadj.) Rs166.5115.9-  
Cash flow per share (Unadj.) Rs181.8148.2-  
Dividends per share (Unadj.) Rs75.0085.56-  
Dividend yield (eoy) %1.32.9 43.7%  
Book value per share (Unadj.) Rs828.6495.1-  
Shares outstanding (eoy) m42.064,366.00-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x5.73.9 146.8%   
Avg P/E ratio x35.225.2 139.7%  
P/CF ratio (eoy) x32.219.7 163.5%  
Price / Book Value ratio x7.15.9 119.8%  
Dividend payout %45.173.8 61.0%   
Avg Mkt Cap Rs m246,28412,747,563 1.9%   
No. of employees `0004.0129.2 3.1%   
Total wages/salary Rs m5,2770-   
Avg. sales/employee Rs Th10,837.325,384.3 42.7%   
Avg. wages/employee Rs Th1,325.00-   
Avg. net profit/employee Rs Th1,757.73,917.1 44.9%   
INCOME DATA
Net Sales Rs m43,1653,279,657 1.3%  
Other income Rs m2,5747,130 36.1%   
Total revenues Rs m45,7393,286,787 1.4%   
Gross profit Rs m8,834833,069 1.1%  
Depreciation Rs m644140,889 0.5%   
Interest Rs m2034,438 0.1%   
Profit before tax Rs m10,744664,873 1.6%   
Minority Interest Rs m0-1,854 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,743156,931 2.4%   
Profit after tax Rs m7,001506,087 1.4%  
Gross profit margin %20.525.4 80.6%  
Effective tax rate %34.823.6 147.6%   
Net profit margin %16.215.4 105.1%  
BALANCE SHEET DATA
Current assets Rs m45,6202,351,902 1.9%   
Current liabilities Rs m17,4262,308,266 0.8%   
Net working cap to sales %65.31.3 4,909.2%  
Current ratio x2.61.0 256.9%  
Inventory Days Days3525 140.7%  
Debtors Days Days2435 66.5%  
Net fixed assets Rs m5,1381,043,333 0.5%   
Share capital Rs m421125,488 0.3%   
"Free" reserves Rs m34,4310-   
Net worth Rs m34,8512,161,816 1.6%   
Long term debt Rs m01,359,192 0.0%   
Total assets Rs m54,1276,561,240 0.8%  
Interest coverage x530.220.3 2,611.2%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.5 159.5%   
Return on assets %13.08.2 157.5%  
Return on equity %20.123.4 85.8%  
Return on capital %30.919.8 155.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m2,8280-   
CASH FLOW
From Operations Rs m7,230756,850 1.0%  
From Investments Rs m-4,465-535,178 0.8%  
From Financial Activity Rs m-3,634-258,890 1.4%  
Net Cashflow Rs m-868-37,219 2.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for COCA COLA (US) is United States Dollars. All data has been converted at 71.3 Rs / USD

Compare GSK CONSUMER With: TIGER BRANDS (S. Africa)  NESTLE (Switz.)  AVI LTD. (S. Africa)  

Compare GSK CONSUMER With: NESTLE  KRBL LIMITED  GOODRICKE  LAKSHMI OVERSEAS IND.  RUCHI SOYA INDUSTRIES  



Today's Market

Sensex Ends 274 Points Lower; IT and Energy Stocks Witness Selling(Closing)

Share markets in India continued to witness selling pressure during closing hours and ended their trading session on a negative note.

Related Views On News

GSK CONSUMER Announces Quarterly Results (2QFY19); Net Profit Up 43.2% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, GSK CONSUMER has posted a net profit of Rs 3 bn (up 43.2% YoY). Sales on the other hand came in at Rs 13 bn (up 14.0% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (1QFY19); Net Profit Up 51.6% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 51.6% YoY). Sales on the other hand came in at Rs 11 bn (up 5.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK Consumer: On the Recovery Path (Quarterly Results Update - Detailed)

Jun 20, 2017

While GSK consumer reported muted revenue growth, volumes are seen to be recovering.

GSK Consumer: Price Hike Hurts Volumes (Quarterly Results Update - Detailed)

Nov 30, 2016

GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.

Prataap Snacks Ltd. (IPO)

Sep 21, 2017

Is the Prataap Snacks IPO worth your attention?

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

5G Stocks: Cutting-Edge Technology that Could Make You Very Rich...(Profit Hunter)

Nov 12, 2018

A brand new technology and a stock that could soar with the upcoming 5G rollout.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Investing In Small Cap Funds? Read This Before You Invest(Outside View)

Nov 19, 2018

PersonalFN explains the care to take when investing in small-cap funds and the approach to follow.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Nov 21, 2018 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER - RUCHI SOYA INDUSTRIES COMPARISON

COMPARE GSK CONSUMER WITH

MARKET STATS